Several studies have documented that blood biomarkers can improve basic prognostic models in radiotherapy and radio-chemotherapy for non-small cell lung cancer. | Blood serum proteins as biomarkers for prediction of survival locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer